4//SEC Filing
Milanova Tsveta 4
Accession 0001439222-24-000044
CIK 0001439222other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:06 PM ET
Size
7.9 KB
Accession
0001439222-24-000044
Insider Transaction Report
Form 4
Milanova Tsveta
Chief Commercial Officer
Transactions
- Award
Restricted stock units
2024-03-01+17,000→ 17,000 total→ Common stock (17,000 underlying) - Award
Stock options (right to buy)
2024-03-01+60,000→ 60,000 totalExercise: $32.27Exp: 2034-03-01→ Common stock (60,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F2]The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments.
- [F3]This option was granted on March 1, 2024. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2025, with the remaining 75% vesting in 36 equal monthly installments thereafter.
Documents
Issuer
AGIOS PHARMACEUTICALS, INC.
CIK 0001439222
Entity typeother
Related Parties
1- filerCIK 0001957180
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:06 PM ET
- Size
- 7.9 KB